Annual Cash & Cash Equivalents
$1.04 M
-$4.32 M-80.65%
September 30, 2024
Summary
- As of February 12, 2025, EDSA annual cash & cash equivalents is $1.04 million, with the most recent change of -$4.32 million (-80.65%) on September 30, 2024.
- During the last 3 years, EDSA annual cash & cash equivalents has fallen by -$6.80 million (-86.77%).
- EDSA annual cash & cash equivalents is now -88.17% below its all-time high of $8.77 million, reached on September 1, 2014.
Performance
EDSA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.04 M
-$1.00 M-49.17%
September 30, 2024
Summary
- As of February 12, 2025, EDSA quarterly cash and cash equivalents is $1.04 million, with the most recent change of -$1.00 million (-49.17%) on September 30, 2024.
- Over the past year, EDSA quarterly cash and cash equivalents has dropped by -$1.76 million (-62.95%).
- EDSA quarterly cash and cash equivalents is now -93.84% below its all-time high of $16.84 million, reached on November 30, 2013.
Performance
EDSA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EDSA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -80.7% | -63.0% |
| 3 y3 years | -86.8% | -83.9% |
| 5 y5 years | -79.4% | -83.9% |
EDSA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.8% | at low | -93.5% | at low |
| 5 y | 5-year | -86.8% | at low | -93.5% | at low |
| alltime | all time | -88.2% | +2083.8% | -93.8% | +485.4% |
Edesa Biotech Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $1.04 M(-80.7%) | $1.04 M(-49.2%) |
| Jun 2024 | - | $2.04 M(-27.1%) |
| Mar 2024 | - | $2.80 M(-34.4%) |
| Dec 2023 | - | $4.27 M(-20.4%) |
| Sep 2023 | $5.36 M(-24.4%) | $5.36 M(-17.0%) |
| Jun 2023 | - | $6.46 M(-13.6%) |
| Mar 2023 | - | $7.47 M(-9.7%) |
| Dec 2022 | - | $8.27 M(+16.6%) |
| Sep 2022 | $7.09 M(-9.5%) | $7.09 M(-44.6%) |
| Jun 2022 | - | $12.81 M(-19.4%) |
| Mar 2022 | - | $15.89 M(+170.2%) |
| Dec 2021 | - | $5.88 M(-25.0%) |
| Sep 2021 | $7.84 M(+8.7%) | $7.84 M(-2.6%) |
| Jun 2021 | - | $8.05 M(-26.6%) |
| Mar 2021 | - | $10.97 M(+73.9%) |
| Dec 2020 | - | $6.31 M(-12.6%) |
| Sep 2020 | $7.21 M(+43.4%) | $7.21 M(+27.9%) |
| Jun 2020 | - | $5.64 M(-19.3%) |
| Mar 2020 | - | $6.99 M(+82.6%) |
| Dec 2019 | - | $3.83 M(-39.9%) |
| Sep 2019 | $5.03 M(+19.1%) | - |
| Jun 2019 | - | $6.36 M(-17.2%) |
| Mar 2019 | - | $7.68 M(+4.3%) |
| Dec 2018 | - | $7.36 M(+74.3%) |
| Sep 2018 | $4.23 M(-7.6%) | $4.23 M(-27.4%) |
| Jun 2018 | - | $5.82 M(+76.8%) |
| Mar 2018 | - | $3.29 M(-24.6%) |
| Dec 2017 | - | $4.37 M(-4.4%) |
| Sep 2017 | $4.57 M | $4.57 M(+25.3%) |
| Jun 2017 | - | $3.65 M(-20.7%) |
| Mar 2017 | - | $4.60 M(-21.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | - | $5.89 M(-20.6%) |
| Sep 2016 | $7.42 M(+87.5%) | $7.42 M(+54.9%) |
| Jun 2016 | - | $4.79 M(-19.7%) |
| Mar 2016 | - | $5.96 M(+53.4%) |
| Dec 2015 | - | $3.89 M(-1.7%) |
| Sep 2015 | $3.96 M(-54.9%) | $3.96 M(-61.1%) |
| Jun 2015 | - | $10.16 M(-8.8%) |
| Mar 2015 | - | $11.15 M(-12.7%) |
| Dec 2014 | - | $12.76 M(+51.5%) |
| Sep 2014 | $8.77 M(+4.1%) | - |
| Aug 2014 | $8.42 M(+7.2%) | $8.42 M(-43.0%) |
| May 2014 | - | $14.79 M(-6.7%) |
| Feb 2014 | - | $15.84 M(-6.0%) |
| Nov 2013 | - | $16.84 M(+114.3%) |
| Aug 2013 | $7.86 M(+686.8%) | $7.86 M(+339.4%) |
| May 2013 | - | $1.79 M(+94.0%) |
| Feb 2013 | - | $921.80 K(-43.5%) |
| Nov 2012 | - | $1.63 M(+63.4%) |
| Aug 2012 | $999.00 K(-75.9%) | $999.00 K(-48.9%) |
| May 2012 | - | $1.95 M(-33.6%) |
| Feb 2012 | - | $2.95 M(-27.7%) |
| Nov 2011 | - | $4.08 M(-1.7%) |
| Aug 2011 | $4.15 M(+106.9%) | $4.15 M(-18.7%) |
| May 2011 | - | $5.10 M(-15.2%) |
| Feb 2011 | - | $6.01 M(-6.8%) |
| Nov 2010 | - | $6.45 M(+222.0%) |
| Aug 2010 | $2.00 M(+738.2%) | $2.00 M(-24.6%) |
| May 2010 | - | $2.66 M(+206.9%) |
| Jan 2010 | - | $866.10 K(+388.8%) |
| Oct 2009 | - | $177.20 K(-25.9%) |
| Apr 2009 | $239.00 K(+403.2%) | $239.00 K |
| Apr 2008 | $47.50 K | - |
FAQ
- What is Edesa Biotech annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Edesa Biotech?
- What is Edesa Biotech annual cash & cash equivalents year-on-year change?
- What is Edesa Biotech quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Edesa Biotech?
- What is Edesa Biotech quarterly cash and cash equivalents year-on-year change?
What is Edesa Biotech annual cash & cash equivalents?
The current annual cash & cash equivalents of EDSA is $1.04 M
What is the all time high annual cash & cash equivalents for Edesa Biotech?
Edesa Biotech all-time high annual cash & cash equivalents is $8.77 M
What is Edesa Biotech annual cash & cash equivalents year-on-year change?
Over the past year, EDSA annual cash & cash equivalents has changed by -$4.32 M (-80.65%)
What is Edesa Biotech quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EDSA is $1.04 M
What is the all time high quarterly cash and cash equivalents for Edesa Biotech?
Edesa Biotech all-time high quarterly cash and cash equivalents is $16.84 M
What is Edesa Biotech quarterly cash and cash equivalents year-on-year change?
Over the past year, EDSA quarterly cash and cash equivalents has changed by -$1.76 M (-62.95%)